Your episodic migraine research study application has been received.
Because people with migraine may be unable to find an effective medication that helps prevent migraine recurrence, it’s important to continue searching for treatments that offer migraine relief. In this study we want to evaluate an investigational intravenous medication for the treatment of migraine headaches.
Study participants will receive (2) IV infusions of study medication or placebo 12 weeks apart. If you qualify, you will receive study-related exams and study medication at no cost. In addition, you may be compensated up to $600 for your time and travel expenses.
One of our Research Nurses will reach out to you within 24 to 48 hours. Alternatively, you may contact us during business hours, Monday through Friday between 8:00 a.m. and 5:00 p.m. by calling (734) 677-6000 and selecting option 4.
